GO

Gilad Ofek

DU Duke University: 2 patents #648 of 2,315Top 30%
CU Columbia University: 2 patents #655 of 2,492Top 30%
UM University Of Maryland: 1 patents #209 of 857Top 25%
UP University Of Maryland, College Park: 1 patents #377 of 1,056Top 40%
📍 Washington, DC: #218 of 3,063 inventorsTop 8%
🗺 District of Columbia: #218 of 3,063 inventorsTop 8%
Overall (All Time): #442,200 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12043660 10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use Peter Kwong, Young Do Kwon, Ivelin Georgiev, Baoshan Zhang, Krisha McKee +15 more 2024-07-23
11981707 Prefusion RSV F proteins and their use Peter Kwong, Barney Graham, Jason McLellan, Jeffrey Boyington, Lei Chen +14 more 2024-05-14
11944681 HIV-1 neutralizing antibodies and uses thereof Barton F. Haynes, Hua-Xin Liao, M. Anthony Moody, LaTonya Williams, Kevin J. WIEHE 2024-04-02
11236152 Neutralizing antibodies to HIV-1 GP41 and their use Peter Kwong, Young Do Kwon, Ivelin Georgiev, Baoshan Zhang, Krisha McKee +15 more 2022-02-01
11130785 Prefusion RSV F proteins and their use Peter Kwong, Barney Graham, Jason McLellan, Jeffrey Boyington, Lei Chen +14 more 2021-09-28
11071783 HIV-1 neutralizing antibodies and uses thereof Barton F. Haynes, Hua-Xin Liao, M. Anthony Moody, LaTonya Williams, Kevin J. WIEHE 2021-07-27
10047148 Neutralizing GP41 antibodies and their use Mark Connors, Jinghe Huang, Leo B. Laub, Peter Kwong, Gary J. Nabel +6 more 2018-08-14
10017543 Prefusion RSV F proteins and their use Peter Kwong, Barney Graham, Jason McLellan, Jeffrey Boyington, Lei Chen +14 more 2018-07-10
9783595 Neutralizing GP41 antibodies and their use Mark Connors, Jinghe Huang, Leo B. Laub, Peter Kwong, Gary J. Nabel +6 more 2017-10-10
9475862 Neutralizing GP41 antibodies and their use Mark Connors, Jinghe Huang, Leo B. Laub, Peter Kwong, Gary J. Nabel +6 more 2016-10-25
8147840 Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid Peter Kwong, Richard Wyatt, Min Tang 2012-04-03